Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine shortage
Marketing
Glass half-full? AstraZeneca CEO Soriot defends coronavirus shot
After months of delays, AstraZeneca still says its COVID-19 vaccine will be filed in the U.S. soon. With so many others shots available, why bother?
Beth Snyder Bulik
May 3, 2021 10:19am
Merck, Pfizer pneumonia vaccines running low in EU
Oct 23, 2020 10:45am
Daiichi Sankyo comes up far short in avian flu vaccine effort
May 22, 2019 10:19am
Kaléo strikes Walgreens pact to stock Auvi-Q nationwide
Sep 6, 2018 12:05pm
FiercePharmaAsia—Astellas, Brii's $260M, Sun and more
May 25, 2018 9:30am
Merck's Gardasil 9 vaccine runs scarce in U.K.
Apr 13, 2018 10:12am
